Latest news
Loading news…
Relay Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2016 101-250 employees For Profit
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
329
Ticker
RLAY
NASDAQ
Patents
42
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- RLAY
- Exchange
- NASDAQ
- IPO date
- Jul 16, 2020
- Raised at IPO
- $400M
- Valuation at IPO
- $2B
- Valuation range
- $1B to $10B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 28
- Active products
- 9
- Patents granted
- 42
- Trademarks
- 6
- Top patent class
- Organic Chemistry
- IT spend
- $645K
Company Info
- Founded
- 2016
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 5
- Sub-organizations
- 1
- News articles
- 211
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Diversity spotlight
- Women Founded
- Exit date
- Jul 16, 2020
Signals & Scores
- Heat score
- High
- Growth score
- Medium
- Trend (7d)
- -1.5
- Trend (30d)
- -4.1
- Trend (90d)
- 2.7
- Last leadership hire
- Nov 4, 2025
- Last layoff mention
- May 5, 2025
Acquisitions by Relay Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Relay Therapeutics
President and CEO
Chief Operating Officer, R&D
Chief Corporate Development Officer
SVP, AI
President of Research and Development
329
professional contacts at Relay Therapeutics
Contact execs at Relay Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Relay Therapeutics
Loading news…
FAQs about Relay Therapeutics
People who checked this page also checked these
Sectors Relay Therapeutics invests & acquires in
Browse the full Acquirezy directory.